Univest
Univest
  • Markets

Nifty Pharma Prediction for Tomorrow, 14 July 2026: Index Nearly Flat at 25,643.35 as Sector Stays on the Sidelines

  • July 13, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Nifty Pharma Prediction for Tomorrow

Nifty Pharma prediction for tomorrow 14 July 2026: index at 25,643.35, down 0.12 percent on Monday. Support 25,470. Resistance 25,740 and 25,900.

Nifty pharma prediction for tomorrow: Nifty Pharma closed at 25,643.35 on Monday, down 30.75 points or 0.12 percent, a near-flat session that saw the sector largely sidelined as IT and geopolitical headlines dominated the day’s flows. This nifty pharma prediction for tomorrow is built on Friday, 10 July 2026’s closing data, the last completed session before markets reopen on Monday, 13 July 2026.

Ankit Jaiswal, Senior Research Analyst at Univest, notes that the Nifty Pharma prediction for tomorrow reflects a defensive sector holding steady through both the market’s sharp opening drop and its later recovery, neither participating meaningfully in the selling nor the rally.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Market Recap Behind the Nifty pharma prediction for tomorrow
  • Nifty pharma prediction for tomorrow: Trend and Key Levels
  • Global Cues for Nifty Pharma Tomorrow
  • Key Triggers in the Nifty pharma prediction for tomorrow
  • Stocks to Watch in the Pharma Sector
  • Risks to the Nifty pharma prediction for tomorrow
  • Conclusion
  • FAQs on the Nifty pharma prediction for tomorrow
    • What is the Nifty Pharma prediction for tomorrow, 14 July 2026?
    • Which analyst gave the Nifty Pharma prediction for tomorrow?
    • Why did Nifty Pharma stay nearly flat on Monday?
    • What would improve the Nifty Pharma prediction for tomorrow’s outlook?

Market Recap Behind the Nifty pharma prediction for tomorrow

The index opened at 25,613.80, touched a high of 25,737.65 and a low of 25,468.85 before closing at 25,643.35, essentially unchanged. Ankit Jaiswal notes that pharma’s stability through Monday’s volatile session, rather than an outright decline during the sharp opening drop, suggests continued underlying resilience even without active buying interest.

Nifty pharma prediction for tomorrow: Trend and Key Levels

Trend: Sideways Between 25,470 and 25,740

Level Type Value
Support 1 25,470
Support 2 25,300
Resistance 1 25,740
Resistance 2 25,900

Ankit Jaiswal flags 25,470 as the key support, with 25,740 as the near-term resistance. A close above 25,900 would suggest pharma is regaining favour, while a break under 25,300 would signal the sector is beginning to see active selling rather than mere sidelining.

Global Cues for Nifty Pharma Tomorrow

Iran re-closed the Strait of Hormuz over the weekend and expanded its strikes to Qatar and the UAE after fresh US attacks on Iranian targets, sending crude oil sharply higher. Equity markets opened deep in the red on Monday but pared most losses as IT stocks rallied hard on earnings optimism. Pharma is largely insulated from these geopolitical and currency-driven cues, since the sector’s fortunes depend more on US generic pricing trends and domestic demand than on Middle East headlines or metal prices.

Key Triggers in the Nifty pharma prediction for tomorrow

These triggers dominate the outlook heading into Monday, 13 July 2026:

  • US generic pricing developments: Any regulatory or pricing news from the US market remains the clearest sector-specific catalyst.
  • Sector rotation dynamics: A pause in the current IT-led rally could see money rotate back into defensives like pharma.
  • HCL Technologies jumped 4.91 percent to Rs 1,221.20 on Monday ahead of its Q1 FY27 results, due after today’s close.

Talk to a SEBI Registered Investment Advisor Before Your Next Trade

Stocks to Watch in the Pharma Sector

Key pharma constituents worth tracking alongside the broader sector outlook.

Sun Pharma: Sun Pharma is a sector bellwether worth tracking for stock-level signals within the pharma space.

Nifty Healthcare: The closely related healthcare index moved in a similarly muted fashion on Monday.

Risks to the Nifty pharma prediction for tomorrow

These factors can invalidate this outlook:

  • Continued sideways drift: If IT and cyclicals keep dominating flows, pharma could see further muted relative performance.
  • US regulatory setback: Any adverse FDA decision would be a clear sector-specific negative.
  • Currency moves: A stronger rupee would reduce the value of pharma’s dollar-denominated export earnings.

Download the Univest iOS App or Univest Android App to track live Nifty Pharma levels and get daily research from SEBI registered analysts.

Conclusion

The Nifty Pharma prediction for tomorrow, 14 July 2026, is sideways between 25,470 and 25,740, after the index stayed essentially flat through Monday’s volatile session. Ankit Jaiswal flags 25,470 as the key support in the Nifty Pharma prediction for tomorrow, with US generic pricing news and a potential rotation shift away from IT the key variables heading into Tuesday.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on the Nifty pharma prediction for tomorrow

What is the Nifty Pharma prediction for tomorrow, 14 July 2026?

Ans. The Nifty Pharma prediction for tomorrow, 14 July 2026, is sideways between 25,470 and 25,740. The index closed at 25,643.35 on Monday, down just 0.12 percent, staying largely sidelined during a volatile session.

Which analyst gave the Nifty Pharma prediction for tomorrow?

Ans. Ankit Jaiswal, Senior Research Analyst at Univest, has shared the Nifty Pharma prediction for tomorrow, flagging 25,470 as the key support level.

Why did Nifty Pharma stay nearly flat on Monday?

Ans. Nifty Pharma fell just 0.12 percent on Monday as IT stocks and geopolitical headlines around the Strait of Hormuz dominated the day’s flows, leaving pharma largely on the sidelines of both the sharp opening drop and the later recovery.

What would improve the Nifty Pharma prediction for tomorrow’s outlook?

Ans. A pause in the current IT-led rally, which would allow money to rotate back into defensives like pharma, or positive US generic pricing news, would be the clearest catalysts for pharma outperformance.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply